**4.4 Results from the analyses of the clinical data of the patients**

We evaluate the distributions of the patients from our study group in the different grades of the Eastern Cooperative Oncology Group (EKOG) performance status scale (Oken et al. 1982)(Figure 6). All the patients with EKOG performance status higher than grade 2 and patients with serious co morbidities were not suitable candidates for alloSCT.

Furthermore, all the obtained results were correlated and consecutively effective treatment strategy for each single acute leukemia patient was selected.
